In this research, a comprehensive analysis was conducted on 30 derivatives of naphthoquinone using computational methods such as 3D-QSAR modeling, assessment of drug similarity, ADMET analysis, molecular docking, and molecular dynamics simulations. The primary aim was to establish robust 3D-QSAR models employing CoMFA, aiming to identify potential novel antibacterial agents targeting Escherichia coli. The QSAR models exhibited strong predictive capabilities, as demonstrated by their assessments (Q2 = 0.613, R2 = 0.902, SEE = 0.063). Utilizing the QSAR model predictions, we devised four novel molecular structures. These structures were subsequently evaluated for drug likeness and ADMET predictions, with two compounds displaying exceptional ADMET predictions and drug likeness. Molecular docking was utilized to explore the interactions between the recently designed molecules, denoted as molecules 1 and 2, and the intended protein target. Of these, compound 2 displayed considerable stability based on the results obtained. To validate this stability, extensive molecular dynamics simulations were performed for 100 nanoseconds at three distinct temperatures, affirming the observed high stability.
Previous Article in event
Previous Article in session
Next Article in event
Next Article in session
In Silico Investigation of 2-Aryloxy-1,4-Naphthoquinone Derivatives as Potential Antibacterials Against Escherichia coli
Published:
01 November 2023
by MDPI
in 9th International Electronic Conference on Medicinal Chemistry
session New Small molecules as drug candidates
Abstract:
Keywords: Keywords: E. coli; QSAR; ADMET; Drug-likness; Molecular dynamics
Comments on this paper
Eduvan Daniel Valencia Cristancho
28 November 2023
Excellent research, however, should provide information on oral bioavailability values, in order to compare them with reference drugs.